Advanced search
Publication Cover
Brain Injury Volume 31, 2017 - Issue 1
Submit an article Journal homepage
547
Views
35
CrossRef citations to date
0
Altmetric
Review Article

The danger zone: Systematic review of the role of HMGB1 danger signalling in traumatic brain injury

Taylor M. ParkerDepartment of Clinical and Translational Science, Creighton University School of Medicine, Omaha, NE, USACorrespondence[email protected]
,
Austin Huy NguyenDepartment of Clinical and Translational Science, Creighton University School of Medicine, Omaha, NE, USA
,
Joshua R. RabangDepartment of Clinical and Translational Science, Creighton University School of Medicine, Omaha, NE, USA
,
Arun-Angelo PatilDivision of Neurosurgery, Creighton University Medical Center, Omaha, NE, USA
&
Devendra K. AgrawalDepartment of Clinical and Translational Science, Creighton University School of Medicine, Omaha, NE, USA
Pages 2-8 | Received 19 Mar 2016, Accepted 06 Jul 2016, Published online: 07 Nov 2016

References

  • Faul M, Xu L, Wald MM CV. Traumatic brain injury in the United States: emergency department visits, hospitalizations, and deaths. Atlanta, GA: Centers Dis. Control Prev. Natl. Cent. Inj. Prev. Control [Internet]. 2010;891–904. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23630120.
  • Woodcock T, Morganti-Kossmann MC. The role of markers of inflammation in traumatic brain injury. Frontiers in Neurology 2013;4:18.
  • Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002;418:191–195.
  • Fink MP. Bench-to-bedside review: high-mobility group box 1 and critical illness. Critical Care 2007;11:229.
  • Matzinger P. The danger model: a renewed sense of self. Science 2002;296:301–305.
  • Yang H, Wang H, Czura CJ, et al. The cytokine activity of HMGB1. J. Leukoc. Biol. [Internet]. 2005 [cited 2016 Sep 20];78:1–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15734795.
  • Gao T-L, Yuan X-T, Yang D, Dai H-L, Wang W-J, Peng X, Shao H-J, Jin Z-F, Fu Z-J. Expression of HMGB1 and RAGE in rat and human brains after traumatic brain injury. Journal of Trauma & Acute Care Surgery 2012;72:643–649.
  • Su X, Wang H, Zhao J, Pan H, Mao L. Beneficial effects of ethyl pyruvate through inhibiting high-mobility group box 1 expression and TLR4/NF-κB pathway after traumatic brain injury in the rat. Mediators of Inflammation 2011;2011:807142.
  • Laird MD, Shields JS, Sukumari-Ramesh S, Kimbler DE, Fessler RD, Shakir B, Youssef P, Yanasak N, Vender JR, Dhandapani KM. High mobility group box protein-1 promotes cerebral edema after traumatic brain injury via activation of toll-like receptor 4. Glia 2014;62:26–38.
  • Wang H, Yang H, Tracey KJ. Extracellular role of HMGB1 in inflammation and sepsis. Journal of Internal Medicine 2004;255:320–331.
  • Gu X-J, Xu J, Ma B-Y, Chen G, Gu P-Y, Wei D, Hu W-X. Effect of glycyrrhizin on traumatic brain injury in rats and its mechanism. Chinese Journal of Traumatology 2014;17:1–7.
  • Au AK, Aneja RK, Bell MJ, Bayir H, Feldman K, Adelson PD, Fink EL, Kochanek PM, Clark RSB. Cerebrospinal fluid levels of high-mobility group box 1 and cytochrome C predict outcome after pediatric traumatic brain injury. Journal of Neurotrauma 2012;29:2013–2021.
  • Wang K-Y, Yu G-F, Zhang Z-Y, Huang Q, Dong X-Q. Plasma high-mobility group box 1 levels and prediction of outcome in patients with traumatic brain injury. Clinica Chimica Acta 2012;413:1737–1741.
  • Okuma Y, Liu K, Wake H, Liu R, Nishimura Y, Hui Z, Teshigawara K, Haruma J, Yamamoto Y, Yamamoto H, Date I, Takahashi HK, Mori S, Nishibori M. Glycyrrhizin inhibits traumatic brain injury by reducing HMGB1-RAGE interaction. Neuropharmacology 2014;85:18–26.
  • Feeney DM, Boyeson MG, Linn RT, Murray HM, Dail WG. Responses to cortical injury: I. Methodology and local effects of contusions in the rat. Brain Research Netherlands 1981;211:67–77.
  • Okuma Y, Liu K, Wake H, Zhang J, Maruo T, Date I, Yoshino T, Ohtsuka A, Otani N, Tomura S, Shima K, Yamamoto Y, Yamamoto H, Takahashi HK, Mori S, Nishibori M. Anti-high mobility group box-1 antibody therapy for traumatic brain injury. Annals of Neurology 2012;72:373–384.
  • Loane DJ, Kumar A. Microglia in the TBI brain: the good, the bad, and the dysregulated. Experimental Neurology 2016;275:316–327.
  • Namas R, Ghuma A, Hermus L, Zamora R, Okonkwo DO, Billiar TR, Vodovotz Y. The acute inflammatory response in trauma /hemorrhage and traumatic brain injury: current state and emerging prospects. Libyan Journal of Medicine 2009;4:97–103.
  • Metting Z, Wilczak N, Rodiger LA, Schaaf JM, van der Naalt J. GFAP and S100B in the acute phase of mild traumatic brain injury. Neurology 2012;78:1428–1433.
  • Zetterberg H, Smith DH, Blennow K. Biomarkers of mild traumatic brain injury in cerebrospinal fluid and blood. Nature Reviews Neurology 2013;9:201–210.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.